Geron Corp financial data

Symbol
GERN on Nasdaq, GERNW on OTC
Industry
Pharmaceutical Preparations
Location
919 East Hillsdale Boulevard, Suite 250, Foster City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
GERON CORPORATION (to 8/5/2005)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 378 % -17.5%
Return On Equity -57 % +9.92%
Return On Assets -35.4 % +20.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 637M shares +7.38%
Common Stock, Shares, Outstanding 606M shares +11.3%
Entity Public Float 2.43B USD +74.3%
Common Stock, Value, Issued 606K USD +11.2%
Weighted Average Number of Shares Outstanding, Basic 646M shares +13.2%
Weighted Average Number of Shares Outstanding, Diluted 646M shares +13.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 29.5M USD +9200%
General and Administrative Expense 83.3M USD +67.2%
Operating Income (Loss) -174M USD +10.4%
Net Income (Loss) Attributable to Parent -175M USD +5.19%
Earnings Per Share, Basic -0.27 USD/shares +15.6%
Earnings Per Share, Diluted -0.27 USD/shares +15.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79M USD +12.8%
Accounts Receivable, after Allowance for Credit Loss, Current 35.9M USD
Inventory, Net 38.7M USD
Assets, Current 491M USD +43.8%
Property, Plant and Equipment, Net 1.31M USD +11.3%
Operating Lease, Right-of-Use Asset 2.88M USD -19%
Assets 594M USD +50.7%
Accounts Payable, Current 8.6M USD +39.5%
Employee-related Liabilities, Current 22.8M USD +65.8%
Accrued Liabilities, Current 35.5M USD -11.8%
Liabilities, Current 88.3M USD -18.3%
Operating Lease, Liability, Noncurrent 2.27M USD -24.6%
Liabilities 313M USD +115%
Accumulated Other Comprehensive Income (Loss), Net of Tax 261K USD +41.1%
Retained Earnings (Accumulated Deficit) -1.77B USD -10.9%
Stockholders' Equity Attributable to Parent 280M USD +13.1%
Liabilities and Equity 594M USD +50.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -62.3M USD -34.3%
Net Cash Provided by (Used in) Financing Activities 148M USD -47.4%
Net Cash Provided by (Used in) Investing Activities 34.2M USD
Common Stock, Shares Authorized 1.35B shares 0%
Common Stock, Shares, Issued 606M shares +11.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 120M USD +114%
Deferred Tax Assets, Valuation Allowance 430M USD +8.78%
Deferred Tax Assets, Gross 431M USD +8.68%
Payments to Acquire Property, Plant, and Equipment 615K USD +65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -174M USD +5.02%
Property, Plant and Equipment, Gross 3.01M USD +24.9%
Operating Lease, Liability, Current 974K USD +2.63%
Deferred Tax Assets, Operating Loss Carryforwards 273M USD +0.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 28.3M USD +7.52%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 682K USD -31.8%
Share-based Payment Arrangement, Expense 31.9M USD +72.3%
Interest Expense 18.5M USD +123%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%